Migraineurs' psychological traits do not influence response to erenumab
Neurol Sci
.
2020 Dec;41(Suppl 2):467-468.
doi: 10.1007/s10072-020-04661-6.
Authors
Claudia Altamura
1
,
Carmelinda Costa
2
,
Luisa Fofi
3
,
Giovanna Viticchi
4
,
Adriana Fallacara
2
,
Nicoletta Brunelli
2
,
Gabriella Egeo
3
,
Cinzia Aurilia
3
,
Simone Migliore
5
,
Piero Barbanti
3
,
Mauro Silvestrini
4
,
Fabrizio Vernieri
2
Affiliations
1
Headache and Neurosonology Unit, Neurology, Policlinico Universitario Campus Bio-Medico, Rome, Italy. c.altamura@unicampus.it.
2
Headache and Neurosonology Unit, Neurology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
3
Headache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.
4
Neurological Clinic, Marche Polytechnic University, Ancona, Italy.
5
Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.
PMID:
32852687
DOI:
10.1007/s10072-020-04661-6
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized*
Humans
Migraine Disorders* / drug therapy
Substances
Antibodies, Monoclonal, Humanized
erenumab